Landauer Inc. (LDR, Financial) filed Quarterly Report for the period ended 2009-12-31.
Landauer Inc. has a market cap of $538.44 million; its shares were traded at around $57.6 with a P/E ratio of 21.25 and P/S ratio of 5.74. The dividend yield of Landauer Inc. stocks is 3.73%. Landauer Inc. had an annual average earning growth of 5.8% over the past 10 years. GuruFocus rated Landauer Inc. the business predictability rank of 3.5-star.LDR is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES, First Pacific Advisors of First Pacific Advisors, LLC.
increase compared to revenues of $22,438 for the same quarter in fiscal
2009. Domestic revenue increased in the first quarter by $1,452, or 8.5%.
The increase in domestic revenue is driven by the contribution from the
Medical Physics segment of $2,145, offset by declines in domestic Radiation
Monitoring revenue. The decline in the domestic radiation monitoring
business is a result of reduced demand in the Homebuyer's radon monitoring
business due to the weakness in the housing market and declines in
occupational monitoring badges and ancillary services primarily related to
customer workforce reductions driven by the impact of the economy.
International revenue growth was $3,343, or 62.2%, driven by: contributions
Selling, general and administrative expense for the first quarter of
fiscal 2010 was $7,804, an increase of $1,311, or 20.2%, compared with
expense of $6,493 for the first quarter of fiscal 2009. The primary
factors contributing to the increase in selling, general and administrative
expense include: $706 increase from the Medical Physics segment; $563
increase related to foreign acquired companies and the impact of the
strengthening of most foreign currencies against the dollar; and $130 of
increased expense spending to replace the Company's information technology
systems that support customer relationship management and the order-to-cash
cycle.
In conjunction with the acquisitions completed during the quarter,
the Company incurred $1,517 ($1,120, after-tax) of acquisition related
transaction and reorganization costs. The transaction costs of
approximately $1,267 were primarily for professional fees with accounting,
financial, legal and tax advisors to support the due diligence, transaction
structure and accounting for the acquisitions. The reorganization costs of
$250 were severance costs to support changes in selected roles in the GPS
organization.
Resulting operating income for the quarter ended December 31, 2009
was $7,757, a decline of 11.9% compared with $8,805 reported in the same
quarter a year ago. For the fiscal 2010 quarter, the Medical Physics
segment had an operating loss of $174, and the Radiation Monitoring segment
had operating income of $9,448 and, as indicated above, the Company
incurred $1,517 of acquisition related transaction and reorganization costs
which were not allocated to either segment.
Resulting net income for the quarter ended December 31, 2009 amounted
to $5,127, or $0.55 per diluted share, compared with $6,142, or $0.66 per
diluted share, for the same quarter in fiscal 2009. The fiscal 2010 net
income was reduced by the effect of the acquisition related transaction and
reorganization costs in the amount of $1,120 after-tax, or $0.12 per
diluted share.
The Company's financing activities were comprised primarily of
borrowings to support acquisitions and the payments of cash dividends to
shareholders. During the first quarter of fiscal 2010, the Company funded
cash dividends of $9,985, or $0.5375 per share for the first quarter of
fiscal 2010 and $0.525 per share for the fourth quarter of fiscal 2009.
During the first quarter of fiscal 2009, the Company paid cash dividends of
$9,549. Such amounts have been provided from operations.
Read the The complete Report
Landauer Inc. has a market cap of $538.44 million; its shares were traded at around $57.6 with a P/E ratio of 21.25 and P/S ratio of 5.74. The dividend yield of Landauer Inc. stocks is 3.73%. Landauer Inc. had an annual average earning growth of 5.8% over the past 10 years. GuruFocus rated Landauer Inc. the business predictability rank of 3.5-star.LDR is in the portfolios of Chuck Royce of ROYCE & ASSOCIATES, First Pacific Advisors of First Pacific Advisors, LLC.
Highlight of Business Operations:
Revenues for the first quarter of fiscal 2010 were $27,234, a 21.4%increase compared to revenues of $22,438 for the same quarter in fiscal
2009. Domestic revenue increased in the first quarter by $1,452, or 8.5%.
The increase in domestic revenue is driven by the contribution from the
Medical Physics segment of $2,145, offset by declines in domestic Radiation
Monitoring revenue. The decline in the domestic radiation monitoring
business is a result of reduced demand in the Homebuyer's radon monitoring
business due to the weakness in the housing market and declines in
occupational monitoring badges and ancillary services primarily related to
customer workforce reductions driven by the impact of the economy.
International revenue growth was $3,343, or 62.2%, driven by: contributions
Selling, general and administrative expense for the first quarter of
fiscal 2010 was $7,804, an increase of $1,311, or 20.2%, compared with
expense of $6,493 for the first quarter of fiscal 2009. The primary
factors contributing to the increase in selling, general and administrative
expense include: $706 increase from the Medical Physics segment; $563
increase related to foreign acquired companies and the impact of the
strengthening of most foreign currencies against the dollar; and $130 of
increased expense spending to replace the Company's information technology
systems that support customer relationship management and the order-to-cash
cycle.
In conjunction with the acquisitions completed during the quarter,
the Company incurred $1,517 ($1,120, after-tax) of acquisition related
transaction and reorganization costs. The transaction costs of
approximately $1,267 were primarily for professional fees with accounting,
financial, legal and tax advisors to support the due diligence, transaction
structure and accounting for the acquisitions. The reorganization costs of
$250 were severance costs to support changes in selected roles in the GPS
organization.
Resulting operating income for the quarter ended December 31, 2009
was $7,757, a decline of 11.9% compared with $8,805 reported in the same
quarter a year ago. For the fiscal 2010 quarter, the Medical Physics
segment had an operating loss of $174, and the Radiation Monitoring segment
had operating income of $9,448 and, as indicated above, the Company
incurred $1,517 of acquisition related transaction and reorganization costs
which were not allocated to either segment.
Resulting net income for the quarter ended December 31, 2009 amounted
to $5,127, or $0.55 per diluted share, compared with $6,142, or $0.66 per
diluted share, for the same quarter in fiscal 2009. The fiscal 2010 net
income was reduced by the effect of the acquisition related transaction and
reorganization costs in the amount of $1,120 after-tax, or $0.12 per
diluted share.
The Company's financing activities were comprised primarily of
borrowings to support acquisitions and the payments of cash dividends to
shareholders. During the first quarter of fiscal 2010, the Company funded
cash dividends of $9,985, or $0.5375 per share for the first quarter of
fiscal 2010 and $0.525 per share for the fourth quarter of fiscal 2009.
During the first quarter of fiscal 2009, the Company paid cash dividends of
$9,549. Such amounts have been provided from operations.
Read the The complete Report
